As of 2025-07-13, the Intrinsic Value of Tetra Bio Pharma Inc (TBP.TO) is -0.46 CAD. This TBP.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.03 CAD, the upside of Tetra Bio Pharma Inc is -1,943.23%.
Based on its market price of 0.03 CAD and our intrinsic valuation, Tetra Bio Pharma Inc (TBP.TO) is overvalued by 1,943.23%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.46 - -0.46 | -0.46 | -1,943.23% |
| P/E | (1.00) - (1.29) | (1.03) | -4210.4% |
| DDM - Stable | (0.81) - (3.39) | (2.10) | -8517.2% |
| DDM - Multi | (1.03) - (3.39) | (1.58) | -6432.2% |
| Market Cap (mil) | 10.58 |
| Beta | 1.87 |
| Outstanding shares (mil) | 423.36 |
| Enterprise Value (mil) | 11.76 |
| Market risk premium | 5.50% |
| Cost of Equity | 9.18% |
| Cost of Debt | 5.00% |
| WACC | 7.94% |